Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma

NCT04432103 is registered in ClinicalTrials.gov with Centro Medico ABC as lead sponsor.

NCT NCT04432103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04432103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Severe and Critical COVID-19 Pneumonia With Convalescent Plasma
Lead sponsor
Centro Medico ABC
Phase
Phase 3
Overall status
Terminated
Start date
August 8, 2020
Completion date
January 29, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19